The amino monosaccharide glucosamine (2-amino-2-deoxy-D-glucose) is a natural component of the glycoproteins present in connective tissue and gastrointestinal mucosal membrane and acts as building block of glycosaminoglycans [1] [2] [3]. Hypothetical mechanisms by which glucosamine exerts its effects relates to glucosamine-induced reversal of the pro-inflammatory and joint-degenerating effects of interleukin-1, via an inhibitory effect on the interleukin-1 intracellular signaling cascade and especially by the reduction in the activation and nuclear translocation of the transcription factor NF-kB. Other putative mechanisms involve glucosamine as an inhibitor of catabolic enzymes, including matrix metalloproteinases [4]. Typically a salt of glucosamine, either the hydrochloride or sulfate, alone or in combination with other ingradients (for example chondroitin sulfate) are formulated into capsules, tablets and liquids for oral administration and have been marketed heavily over the last two decades. Recently, topical preparations of glucosamine, such as creams, gels and patches have also been developed intensely by pharmaceutical industries. This is due to the transdermal delivery route posses several advantages in therapy compared with oral route, such as circumventing first-pass metabolism or other possible problems associated with passage through gastrointestinal tract, producing relatively constant plasma levels of drugs and improving the patient compliance [5].
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Glucosamine does not contain a chromophore absorbing in region useful for UV vis detection. Therefore, in order to improve the detectability of glucosamine by UV vis spectroscopy and obtain adequate retention on hydrophobic stationary phase, HPLC methods with pre-analytical derivatisation procedure involving the reaction of amino group of glucosamine with hydrophobic chromophore should be achieved. In the present research we developed a HPLC method to analyzed glucosamine in cream dosage form and its diffusion liquid. Glucosamine was derivatized using 1-naphthyl isothiocyanate (NITC) forming a derivative, which was analyzed by HPLC using UV detection. The developed method was then validated according ICH guidelines [6] . Reaction of glucosamine with NITC using a standard aqueous solution produced a naphthylthiocarbomyl-glucosamine adduct that exhibited favorable UV absorbing properties. NITC derivatization reaction was not very sensitive to water. However, several approaches were undertaken to minimize its presence. Calibration curves of glucosamine were found to be linear over the range of 1-1200 µg/ml with the lower limit of quantitation (LOQ) of 2.5 µg/g and the limit of detection (LOD) of 0.5 µg/g at a signal-to-noise ratio of 3 . The correlation coefficient was found to be better than 0.99. A typical regression equation was y = 10280x + 60313 (r= 0.9998, n = 5).
The intra-day RSDs were 3 3.15 and 1.75%, and the inter-day RSDs were 4 .06, 4.68 and 1.72% for spiked cream at concentrations of 5, 20 and 100 mg/g, respectively, with the accuracy ranged 96 .60-103.54%. For diffusion liquid the intra-day RSDs were 2.50, 0.33 and 4.84%, and the inter-day RSDs were 2 .74, 1.85 and 4.90% for spiked diffusion liquid at concentrations of 80, 200 and 1200 µg/ml, respectively . The accuracy of determination of glucosamine in diffusion liquid was in the range of 95.50-109 .43% (Table 1 ). The mean of extraction recovery for glucosamine in cream ranged between 95.9 and 97.4% , while recovery of glucosamine in diffusion liquid was more than 97.6%. Application of the validated method in determination of glucosamine in commercial cream dosage form (Mediflex(r)) and our developed cream formulas showed that the average recovery was within 100.0 + 5.0% of label claim, and RSD of 1.6%, indicating excellent precision. The developed method was also applied for in vitro diffusion study [7] of glucosamine from cream dosage form. The results showed a good precision with RSD less than 5%. Study on determination of glucosamine flux through membrane as well as apparent permeability coefficient are currently underway and will be reported elsewhere.
